Tumors Sharply Increased after Ceasing Pazopanib Therapy for a Patient with Advanced Uterine Leiomyosarcoma: Experience of Tumor Flare
Pazopanib has activity in patients with soft-tissue sarcoma. We report an advanced uterine leiomyosarcoma case that suddenly worsened after cessation of pazopanib therapy. A 47-year-old woman had a primary uterine leiomyosarcoma tumor and multiple lung metastases, which progressed during her initial...
Saved in:
Main Authors: | Terumi Tanigawa, Shintaro Morisaki, Hisanobu Fukuda, Shuichiro Yoshimura, Hisayoshi Nakajima, Kohei Kotera |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Obstetrics and Gynecology |
Online Access: | http://dx.doi.org/10.1155/2017/4801650 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma
by: Maurício Fernando Silva Almeida Ribeiro, et al.
Published: (2018-01-01) -
Spontaneous Tumor Lysis Syndrome due to Uterine Leiomyosarcoma with Lung Metastases
by: Vivek Alaigh, et al.
Published: (2017-01-01) -
Aspectual Verbs: a study of cease and continue
by: Geneviève Girard-Gillet
Published: (2017-03-01) -
Demographic Ageing Leads to a Sharply Declining Labour Force Potential
by: Johann Fuchs, et al.
Published: (2022-02-01) -
Women’s experiences of ceasing to breastfeed: Australian qualitative study
by: Jennifer Elizabeth Ayton, et al.
Published: (2019-05-01)